Castle Biosciences, Inc. (CSTL) Stock Total Returns
Growth of $10,000 chart
2021-04-14 to 2026-04-14 to
$
%
%
Loading chart…
Investment Performance
Final Value
$3,556
Total Return
-64.44%
CAGR
-18.69%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +0.41% |
| Median | -1.07% |
| Best | +69.25% |
| Worst | -50.74% |
| % of Windows Positive | 47.0% |
1-Year (252 Trading Days)
| Average | -8.16% |
| Median | -14.93% |
| Best | +174.65% |
| Worst | -78.94% |
| % of Windows Positive | 35.2% |
3-Year (756 Trading Days)
| Average | -21.40% |
| Median | -30.85% |
| Best | +99.65% |
| Worst | -75.56% |
| % of Windows Positive | 25.3% |
Risk Metrics
| Maximum Drawdown | -84.97% |
| Average Drawdown | -60.46% |
| Drawdown Duration | 1155 Trading Days (Unrecovered) |
| Sortino Ratio | 0.14 |
| Calmar Ratio | -0.22 |
| CVaR (5%) | -9.75% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | -37.35% (-80.65% ann.) | $3735.22 | $0.00 | $0.00 | $0.00 |
| 2025 | +45.97% | +$4596.62 | $0.00 | $0.00 | $0.00 |
| 2024 | +23.49% | +$2349.40 | $0.00 | $0.00 | $0.00 |
| 2023 | -8.33% | $832.63 | $0.00 | $0.00 | $0.00 |
| 2022 | -45.09% | $4508.98 | $0.00 | $0.00 | $0.00 |
| 2021 | -36.16% | $3615.79 | $0.00 | $0.00 | $0.00 |
| 2020 | +95.37% | +$9537.39 | $0.00 | $0.00 | $0.00 |
| 2019 partial | +60.61% (+196.95% ann.) | +$6060.75 | $0.00 | $0.00 | $0.00 |
Market Regimes
| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | July 25, 2019 – February 19, 2020 | +48.93% | +100.58% | +$4892.52 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -22.65% | -94.66% | $2264.55 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | +88.69% | +177.76% | +$8868.61 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | -13.46% | -12.81% | $1345.75 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -56.25% | -58.43% | $5625.45 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | +48.67% | +23.85% | +$4866.79 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – April 14, 2026 | -19.73% | -13.07% | $1972.99 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.